Medblue Innovations: Financial Breakdown
Decoding financial health metrics of Medblue Innovations
Total Revenue₹43.7 Lakh86%Prev. FY
Total Expenses₹20.3 Lakh-16%Prev. FY
Profit After Tax₹-60.8K-23%Prev. FY
Total Assets₹1.0 Cr32%Prev. FY
FAQs on Financials of Medblue Innovations
No. In FY25, Medblue Innovations reported a net loss of ₹60.8K, so it was not profitable.
Medblue Innovations's revenue grew 86.3% year-on-year, from ₹23.4 Lakh in FY24 to ₹43.7 Lakh in FY25.
Medblue Innovations's estimated EBITDA for FY25 was ₹91.1K, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY25, Medblue Innovations posted revenue of ₹43.7 Lakh (up 86.3% YoY) and a net loss of ₹60.8K. Explore the full financials of Medblue Innovations here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links